The symposium will be held at the Vetmeduni Vienna on January 31 and February 01, 2019. The symposium invited speakers from the Vienna Life Science community and from the Vetmeduni Vienna who work in basic and translational biomedical sciences to pave the road for new therapeutic concepts. Their research contributions serve as role models for students and early career scientists. We train students of the MSc program ‘Comparative Biomedicine’on our campus under the principle of “One Health – One Medicine”. The symposium is organized and supported by SFB F61 JakStat Monarchies.
The conference will be held at the Sheraton Resort, Rhodes, Greece on June 2-7, 2019.
Organizing committee: Belinda Parker, Leonidas Platanias, Mathias Müller and Serge Y Fuchs.
The Conference is under the sponsorship of Aegean Conferences, a non-profit educational organization promoting science through focused scientific conferences (www.aegeanconferences.org). Registration will be limited to 80-110 participants for this meeting; therefore, there should be ample opportunities for interactions and discussions.
The conference sessions present subject areas focused on:
Role of cytokines in tumor initiation, progression and metastatic disease
Anti-tumorigenic effects of interferons and other cytokines
Cytokine-mediated immune regulation and tumor microenvironment
Cytokines and cancer stem cells
Targeting cytokine pathways for anti-cancer treatment and therapeutic use of cytokines
The program details will be presented soon. Click here to download the flyer
The invitation only meeting on May 6-9, 2018 boasts an outstanding scientific programme and will take place in a beautiful location and inspiring atmosphere. We have invited international experts to complement the scientific programme of the two SFBs, including: Jacqueline Bromberg, New York; Gerard Evan, Cambridge; Thomas Graf, Barcelona; Nancy Hynes, Basel; Shai Izraeli, Tel Aviv; David Levy, New York; A. Tom Look, Harvard; Tak Mak, Toronto
A cooperation of Ludwig Boltzmann Institute for Cancer Research, Ludwig Boltzmann Cluster Oncology, SFB-F47, and SFB-F61